EVEROLIMUS

Formula & Concentration

EVEROLIMUS – everolimus (antineoplastic) 10 mg tablet

Manufacturer

Biocon Biologics Inc.*

*Supplied through partnership with Capital Wholesale Co.

Indications

Nonfunctional neuroendocrine tumor of GI origin; nonfunctional neuroendocrine tumor of lung origin; ER(+), HER2(-) postmenopausal advanced breast cancer; SEGA associated with tuberous sclerosis; renal angiomyolipoma with tuberous sclerosis complex; metastatic renal cell carcinoma; pancreatic neuroendocrine tumor

Product Options

Package Size

NDC #

Presentation

10 mg

70377-0013-23

Tablet

Shelf Life and Storage

Controlled Room Temp (20-25°C)